Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocco Totaro

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|April 6, 2012
Morphological variations of the internal carotid artery: Prevalence, characteristics and association with cerebrovascular diseaseSimona Sacco, Rocco Totaro, Massimo Baldassarre, et al.
The Indian Journal of Medical Research|February 3, 2016
Multiple sclerosis--new treatment modalitiesRocco Totaro, Caterina Di Carmine, Carmine Marini, et al.
JAAD Case Reports|December 2, 2022
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosisMaria Esposito, Andrea De Berardinis, Rocco Totaro, et al.
European Neurology|April 10, 2004
Brain white matter lesions in an italian family with charcot-marie-tooth diseaseSimona Sacco, Rocco Totaro, Stefano Bastianello, et al.
Ultrasound in Medicine & Biology|December 25, 2002
Prolongation of TCD-enhanced Doppler signal by continuous infusion of levovistRocco Totaro, Massimo Baldassarre, Simona Sacco, et al.
Health Economics Review|January 21, 2025
Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis: a systematic reviewCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 14, 2022
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis in ItalyCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Case Reports in Neurological Medicine|January 1, 2019
Posterior Reversible Encephalopathy Syndrome Presenting with Atypical Findings: Report of Two CasesPaolo Cerrone, Patrizia Sucapane, Rocco Totaro, et al.
European Neurology|July 3, 2009
Incidence, case-fatalities and 10-year survival of subarachnoid hemorrhage in a population-based registrySimona Sacco, Rocco Totaro, Danilo Toni, et al.
Neuroimmunomodulation|July 2, 2005
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosisPatrizia Pellegrini, Rocco Totaro, Ida Contasta, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|April 6, 2012
Morphological variations of the internal carotid artery: Prevalence, characteristics and association with cerebrovascular diseaseSimona Sacco, Rocco Totaro, Massimo Baldassarre, et al.
The Indian Journal of Medical Research|February 3, 2016
Multiple sclerosis--new treatment modalitiesRocco Totaro, Caterina Di Carmine, Carmine Marini, et al.
JAAD Case Reports|December 2, 2022
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosisMaria Esposito, Andrea De Berardinis, Rocco Totaro, et al.
European Neurology|April 10, 2004
Brain white matter lesions in an italian family with charcot-marie-tooth diseaseSimona Sacco, Rocco Totaro, Stefano Bastianello, et al.
Ultrasound in Medicine & Biology|December 25, 2002
Prolongation of TCD-enhanced Doppler signal by continuous infusion of levovistRocco Totaro, Massimo Baldassarre, Simona Sacco, et al.
Health Economics Review|January 21, 2025
Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis: a systematic reviewCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 14, 2022
Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis in ItalyCarlo Lazzaro, Roberto Bergamaschi, Mauro Zaffaroni, et al.
Case Reports in Neurological Medicine|January 1, 2019
Posterior Reversible Encephalopathy Syndrome Presenting with Atypical Findings: Report of Two CasesPaolo Cerrone, Patrizia Sucapane, Rocco Totaro, et al.
European Neurology|July 3, 2009
Incidence, case-fatalities and 10-year survival of subarachnoid hemorrhage in a population-based registrySimona Sacco, Rocco Totaro, Danilo Toni, et al.
Neuroimmunomodulation|July 2, 2005
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosisPatrizia Pellegrini, Rocco Totaro, Ida Contasta, et al.
Pageof 7